These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17297074)

  • 1. A research agenda for assessing the potential contribution of genomic medicine to tobacco control.
    Hall WD
    Tob Control; 2007 Feb; 16(1):53-8. PubMed ID: 17297074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smokers' beliefs about the tobacco control potential of "a gene for smoking": a focus group study.
    Waters EA; Ball L; Carter K; Gehlert S
    BMC Public Health; 2014 Nov; 14():1218. PubMed ID: 25424390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helping smokers quit through pharmacogenetics.
    Lerman C
    LDI Issue Brief; 2006; 11(6):1-4. PubMed ID: 16827222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacogenetics in the treatment of tobacco addiction].
    Quaak M; van Schooten FJ; van Schayck CP
    Tijdschr Psychiatr; 2013; 55(11):891-8. PubMed ID: 24242150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between tobacco industry denormalization beliefs, tobacco control community discontent and smokers' level of nicotine dependence.
    Kushnir V; Selby P; Cunningham JA
    Addict Behav; 2013 Jul; 38(7):2273-8. PubMed ID: 23583832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical issues raised by a ban on the sale of electronic nicotine devices.
    Hall W; Gartner C; Forlini C
    Addiction; 2015 Jul; 110(7):1061-7. PubMed ID: 25845485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking.
    Caron L; Karkazis K; Raffin TA; Swan G; Koenig BA
    Nicotine Tob Res; 2005 Apr; 7(2):181-97. PubMed ID: 16036275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of nicotine addiction liability: ethical and social policy implications.
    Hall WD; Gartner CE; Carter A
    Addiction; 2008 Mar; 103(3):350-9. PubMed ID: 18190673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathways to precision medicine in smoking cessation treatments.
    Chen LS; Horton A; Bierut L
    Neurosci Lett; 2018 Mar; 669():83-92. PubMed ID: 27208830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.
    Quaak M; van Schayck CP; Knaapen AM; van Schooten FJ
    Mutat Res; 2009 Jul; 667(1-2):44-57. PubMed ID: 19028511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing nicotine dependence in NSW hospitals under the Smoke-free Health Care Policy.
    Mendelsohn C
    Public Health Res Pract; 2015 Jul; 25(3):e2531533. PubMed ID: 26243492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up.
    Benowitz NL; Nardone N; Dains KM; Hall SM; Stewart S; Dempsey D; Jacob P
    Addiction; 2015 Oct; 110(10):1667-75. PubMed ID: 26198394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Support for a tobacco endgame and increased regulation of the tobacco industry among New Zealand smokers: results from a National Survey.
    Edwards R; Wilson N; Peace J; Weerasekera D; Thomson GW; Gifford H
    Tob Control; 2013 May; 22(e1):e86-93. PubMed ID: 22535362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing smoking during pregnancy: the importance of maternal knowledge of the health hazards and of the treatment options available.
    Bertani AL; Garcia T; Tanni SE; Godoy I
    J Bras Pneumol; 2015; 41(2):175-81. PubMed ID: 25972970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized medicine and tobacco-related health disparities: is there a role for genetics?
    Carlsten C; Halperin A; Crouch J; Burke W
    Ann Fam Med; 2011; 9(4):366-71. PubMed ID: 21747109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identifying addictive behaviors among adolescents: a school-based survey].
    Chéron-Launay M; Baha M; Mautrait C; Lagrue G; Le Faou AL
    Arch Pediatr; 2011 Jul; 18(7):737-44. PubMed ID: 21652184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extreme solutions for those who do not succeed to quit smoking. About smokeless tobacco and harm reduction (part II)].
    Trofor A; Eşanu V; Frasilă EL
    Pneumologia; 2008; 57(3):178-81. PubMed ID: 18998333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of tobacco smoking in adolescents: treatment implications.
    Moolchan ET; Ernst M; Henningfield JE
    J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):682-93. PubMed ID: 10846302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking cessation should have more emphasis within Tobacco Control? The case for.
    Bolliger CT
    Health Policy; 2009 Jul; 91 Suppl 1():S31-6. PubMed ID: 19735856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.